Tarsus Pharmaceuticals welcomes Wendy Yarno to its Board of Directors

– USA, CA –  Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye, today announced the appointment of Wendy Yarno to its Board of Directors and its audit committee.…